NO20081311L - Prosess - Google Patents

Prosess

Info

Publication number
NO20081311L
NO20081311L NO20081311A NO20081311A NO20081311L NO 20081311 L NO20081311 L NO 20081311L NO 20081311 A NO20081311 A NO 20081311A NO 20081311 A NO20081311 A NO 20081311A NO 20081311 L NO20081311 L NO 20081311L
Authority
NO
Norway
Prior art keywords
particles
substantially water
stable dispersion
submicron
insoluble substance
Prior art date
Application number
NO20081311A
Other languages
English (en)
Norwegian (no)
Inventor
Lennart Lindfors
Urban Skantze
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20081311L publication Critical patent/NO20081311L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20081311A 2005-08-12 2008-03-12 Prosess NO20081311L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0501807 2005-08-12
PCT/SE2006/000933 WO2007021228A1 (en) 2005-08-12 2006-08-09 Process

Publications (1)

Publication Number Publication Date
NO20081311L true NO20081311L (no) 2008-05-13

Family

ID=37757817

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081311A NO20081311L (no) 2005-08-12 2008-03-12 Prosess

Country Status (13)

Country Link
US (1) US20080193534A1 (enExample)
EP (1) EP1915131A4 (enExample)
JP (1) JP2009505976A (enExample)
KR (1) KR20080033383A (enExample)
CN (1) CN101242809A (enExample)
AU (1) AU2006280511A1 (enExample)
BR (1) BRPI0614904A2 (enExample)
CA (1) CA2618468A1 (enExample)
IL (1) IL188971A0 (enExample)
MX (1) MX2008001919A (enExample)
NO (1) NO20081311L (enExample)
WO (1) WO2007021228A1 (enExample)
ZA (1) ZA200800919B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010517759A (ja) * 2007-02-09 2010-05-27 アストラゼネカ・アクチエボラーグ 水性媒体中における固体非晶質サブミクロン粒子の安定な分散体を製造する方法
TW200848039A (en) * 2007-02-09 2008-12-16 Astrazeneca Ab Pharmaceutical compositions
US8920682B2 (en) * 2010-03-19 2014-12-30 Eastern Michigan University Nanoparticle dispersions with ionic liquid-based stabilizers
KR102803055B1 (ko) * 2019-03-27 2025-04-30 신젠타 크롭 프로텍션 아게 결정 성장이 감소된 살진균제 제형

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
US4832953A (en) * 1987-08-13 1989-05-23 Alza Corporation Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
FR2651680B1 (fr) * 1989-09-14 1991-12-27 Medgenix Group Sa Nouveau procede de preparation de microparticules lipidiques.
US5110717A (en) * 1990-12-17 1992-05-05 Eastman Kodak Company Stability improvement of amorphous particle dispersions
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
DE4327063A1 (de) * 1993-08-12 1995-02-16 Kirsten Dr Westesen Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
DE4329446A1 (de) * 1993-09-01 1995-03-02 Basf Ag Verfahren zur Herstellung von feinteiligen Farb- oder Wirkstoffzubereitungen
GB9319129D0 (en) * 1993-09-15 1993-11-03 Dowelanco Ltd Storage and dilution of stable aqueous dispersions
FR2714057B1 (fr) * 1993-12-17 1996-03-08 Sanofi Elf Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
PT901786E (pt) * 1997-08-11 2007-08-07 Pfizer Prod Inc Disperções farmacêuticas sólidas com biodisponibilidade melhorada
US6375986B1 (en) * 2000-09-21 2002-04-23 Elan Pharma International Ltd. Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
US6267989B1 (en) * 1999-03-08 2001-07-31 Klan Pharma International Ltd. Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions
JP2004502642A (ja) * 2000-02-11 2004-01-29 ブリストル−マイヤーズ　スクイブ　カンパニー カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用
AU2001257115B2 (en) * 2000-04-20 2005-01-27 Rtp Pharma Inc. Improved water-insoluble drug particle process
PT1416917E (pt) * 2001-08-06 2007-08-16 Astrazeneca Ab ''dispersão aquosa compreendendo nanopartículas estáveis de um triglicérido de cadeia média (mct) activo insolúvel em água e um do tipo excipiente''
WO2003059319A1 (en) * 2002-01-14 2003-07-24 Dow Global Technologies Inc. Drug nanoparticles from template emulsions
DE60320940D1 (de) * 2002-02-01 2008-06-26 Pfizer Prod Inc Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
US6825209B2 (en) * 2002-04-15 2004-11-30 Research Triangle Institute Compounds having unique CB1 receptor binding selectivity and methods for their production and use
CA2489153A1 (en) * 2002-06-11 2003-12-18 Merck Patent Gesellschaft Mit Beschraenkter Haftung Modified byrodin 1 with reduced immunogenicity
US7390505B2 (en) * 2003-01-31 2008-06-24 Elan Pharma International, Ltd. Nanoparticulate topiramate formulations
GB0302672D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
US20060198856A1 (en) * 2005-03-01 2006-09-07 Keith Whitehead Ibuprofen suspension stabilized with docusate sodium

Also Published As

Publication number Publication date
JP2009505976A (ja) 2009-02-12
EP1915131A1 (en) 2008-04-30
CA2618468A1 (en) 2007-02-22
EP1915131A4 (en) 2012-07-25
CN101242809A (zh) 2008-08-13
ZA200800919B (en) 2008-12-31
BRPI0614904A2 (pt) 2012-12-25
AU2006280511A1 (en) 2007-02-22
WO2007021228A1 (en) 2007-02-22
IL188971A0 (en) 2008-08-07
US20080193534A1 (en) 2008-08-14
KR20080033383A (ko) 2008-04-16
MX2008001919A (es) 2008-03-24

Similar Documents

Publication Publication Date Title
Huang et al. Advanced technologies for the preservation of mammalian biospecimens
Hunt Cryopreservation: vitrification and controlled rate cooling
Karlsson et al. Long-term storage of tissues by cryopreservation: critical issues
CN101971796B (zh) 无蛋白非程序细胞冻存液
Boomsma et al. Renalase, a catecholamine-metabolising enzyme?
Markarian et al. Glass-forming property of the system diethyl sulphoxide/water and its cryoprotective action on Escherichia coli survival
JP2011234727A (ja) シリンジでの大きな細胞塊の送出、および細胞を凍結保存する関連の方法
FR2834295A1 (fr) Cristaux de glucokinase et leurs methodes de culture
CN107047542A (zh) 一种无血清细胞冻存液
CY1107059T1 (el) Υδατικη διασπορα που περιεχει σταθερα νανοσωματιδια μιας αδιαλυτης στο νερο δραστικης ουσιας κι ενα εκδοχο οπως τα τριγλυκεριδια μεσης αλυσιδας (mct)
CN102648708A (zh) 一种用于胚胎或细胞的冷冻液及其用途
Capicciotti et al. Modulation of antifreeze activity and the effect upon post-thaw HepG2 cell viability after cryopreservation
Jadhav et al. Insight into compatible solutes from halophiles: exploring significant applications in biotechnology
US20070042337A1 (en) Isochoric method and device for reducing the probability of ice nucleation during preservation of biological matter at subzero centigrade temperatures
JP5313146B2 (ja) 水溶性化合物のための安定な水性懸濁濃縮処方物
CA2496540A1 (en) Stable ophthalmic solution comprising latanoprost as active ingredient
JP2022527582A (ja) ケト酸を含む細胞培養培地
RU2498570C1 (ru) Раствор для хранения роговицы
DE602006008822D1 (de) Herstellung von kolloidale teilchen enthaltenden pulvern
US20250230417A1 (en) Non-freezing refrigerated storage liquid and storage method for stem cells
JP2002101869A (ja) 脱水ストレス保護剤
JPH06321713A (ja) 水田用懸濁状除草剤組成物
Mondal A simple method for cryopreservation of MDBK cells using trehalose and storage at− 80 C
CN109874780A (zh) 渗透性保护剂、无血清冻存液以及该无血清冻存液的制备与使用方法
CN101243793A (zh) 乙酰乳酸合成酶ahas抑制剂组合物

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application